| Novartis Pharma Schweiz AG - Scemblix 40 mg, Filmtabletten | | 68441 | | 02 | | Scemblix 40 mg | | Filmtabletten | | L01EA06 | | | | 09.06.2022 | | |
| | Composition | | asciminibum 40 mg ut asciminibi hydrochloridum 43.24 mg, lactosum monohydricum 86.22 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carmellosum natricum conexum, poly(alcohol vinylicus), E 171, magnesii stearas, talcum, silica colloidalis anhydrica, lecithinum, E 172 (rubrum), E 172 (nigrum), xanthani gummi, pro compresso obducto corresp. natrium max. 0.93 mg. | | Packungsbestandteile | | Coated tablets | | | | | | BAG: Active Agent | Dose |
|---|
| | 40 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | | | | | color. | | | | color. | | | | | | Lactose Monohydrate | 86.22 mg | | | Lecithine | | | | | | | | | | | | | | | | Silica Colloidalis Anhydrica | | | | Talcum | | | | | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 60 | 3688.62 | 4028.00 | A | SL | No |
|
|
